Resilience: Craig DeLarge on Digital Mental Health in the Era of COVID-19

Written By Kenny Kane

[audio mp3="https://pdcn.co/e/rss.art19.com/episodes/5eb6c6f6-d005-4877-81a7-8ba3afc63735.mp3?rss_browser=BAhJIgljdXJsBjoGRVQ%3D--435795d5c850773aaa4739d968bd77a1dfd6f301"][/audio] Resilience: Craig DeLarge on Digital Mental Health in the Era of COVID-19

Craig DeLarge is a Digital Health Strategist and Educator at the Digital Mental Health Project, a project aimed at effectively using digital technology in the mental health field, aka MentalTech, to combat mental illness. His main missions are to improve health and build up leaders. Craig has also worked with companies such as IMS Health (IQVIA), CMI/Compas, J&J, GSK, Novo Nordisk, Merck and Takeda Pharma International (Singapore) to positively impact the health community. Craig teaches & lectures on various subjects relating to business, communications, leadership, storytelling and visual literacy at the university undergraduate and graduate levels. In this episode, we go into the importance of mental health, the work Craig is doing at the DMHP, mental health tips during COVID-19, as well as bonus tips.


Resources Mentioned In This Episode:

Blog Post —> StressTech & COVID-19

Mental Health America, https://www.mhanational.org/

National Alliance on Mental Illness, https://www.nami.org/




See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Kenny Kane

Kenny Kane is an entrepreneur, writer, and nonprofit innovator with 15+ years of experience leading organizations at the intersection of business, technology, and social impact. He is the CEO of Firmspace, CEO of the Testicular Cancer Foundation, and CTO/co-founder of Gryt Health.

A co-founder of Stupid Cancer, Kenny has built national awareness campaigns and scaled teams across nonprofits, health tech, and real estate. As an author, he writes about leadership, resilience, and building mission-driven organizations.

Previous

COVID-19 Explainer: Dr. Jean-Luc Neptune Tells His Own Story of Surviving the Virus
Next

The Immunotherapy Series, Part Three: Policy and the FDA